Germline and somatic testing can inform treatment and family risk up front, but NGS is often held for recurrence, explained Courtney R. Arn, APRN-CNP.
Implementing Biomarker-Driven Treatment Strategies in Ovarian Cancer
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
2
Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab
3
Frontline Axi-Cel CR Linked With Improved Survival in High-Risk LBCL
4
Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer
5
